EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 07 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
D 28-283
|
419-430-9
|
56533-00-7
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B |
||
|
VP SANDUVOR 3052 LIQUIDE
|
405-670-1
|
119530-69-7
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B |
||
|
SETALUX EPC 4690
|
420-190-2
|
771478-66-1
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
EF-40
|
406-110-9
|
35950-52-8
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
C11-NEODIAMINE
|
412-700-7
|
137605-95-9
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
DP-3337
|
405-710-8
|
23783-26-8
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
D 27-046
|
413-520-1
|
125792-14-5
|
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1 |
||
|
1,3-DICHLOR-4-FLUORBENZOL; B-7
|
406-160-1
|
1435-48-9
|
Acute Tox. 4; STOT RE 2; Skin Irrit. 2 |
||
|
TTP MAGENTA 3
|
405-480-9
|
110260-50-9
|
Acute Tox. 4; STOT RE 2; Skin Irrit. 2 |
||
|
203-868-0
|
111-42-2
|
Acute Tox. 4; STOT RE 2; Skin Irrit. 2; Eye Dam. 1 |
|||